Antibody or Anybody? Considering the Role of MRGPRX2 in Acute Drug-Induced Anaphylaxis and as a Therapeutic Target

por Mackay, Graham A., Fernandopulle, Nithya A., Ding, Jie, McComish, Jeremy, Soeding, Paul F.
Publicado 2021

The effect of substance P and its common in vivo‐formed metabolites on MRGPRX2 and human mast cell activation

por Hsin, Lin, Fernandopulle, Nithya A., Ding, Jie, Lumb, Chris, Veldhuis, Nicholas, Karas, John A., Northfield, Susan E., Mackay, Graham A.
Publicado 2022

Fc Binding by FcγRIIa Is Essential for Cellular Activation by the Anti-FcγRIIa mAbs 8.26 and 8.2

por Wines, Bruce D., Trist, Halina M., Esparon, Sandra, Impey, Rachael E., Mackay, Graham A., Andrews, Robert K., Soares da Costa, Tatiana P., Pietersz, Geoffrey A., Baker, Ross I., Hogarth, P. Mark
Publicado 2021

The Rare Anaphylaxis-Associated FcγRIIa3 Exhibits Distinct Characteristics From the Canonical FcγRIIa1

por Anania, Jessica C., Trist, Halina M., Palmer, Catherine S., Tan, Peck Szee, Kouskousis, Betty P., Chenoweth, Alicia M., Kent, Stephen J., Mackay, Graham A., Hoi, Alberta, Koelmeyer, Rachel, Slade, Charlotte, Bryant, Vanessa L., Hodgkin, Philip D., Aui, Pei Mun, van Zelm, Menno C., Wines, Bruce D., Hogarth, P. Mark
Publicado 2018